SK Bioscience Co Ltd (302440) — Cash Flow Quality Index
SK Bioscience Co Ltd (302440) has a Cash Flow Quality Index of 0.84x as of September 2025. Operating cash flow of ₩20.65 Billion is below net income of ₩24.48 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 302440 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SK Bioscience Co Ltd Cash Flow Quality Index (2018–2023)
Historical Cash Flow Quality Index for SK Bioscience Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 302440 cash flow conversion.
Annual Cash Flow Quality Index for SK Bioscience Co Ltd (2018–2023)
Year-by-year earnings quality comparison for SK Bioscience Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.31x | ₩29.35 Billion | ₩22.32 Billion | ▲ +228.9% |
| 2022 | -1.02x | ₩-124.96 Billion | ₩122.45 Billion | ▼ -167.5% |
| 2021 | 1.51x | ₩536.59 Billion | ₩355.14 Billion | ▼ -58.7% |
| 2020 | 3.66x | ₩120.22 Billion | ₩32.89 Billion | ▲ +200.0% |
| 2019 | 1.22x | ₩21.82 Billion | ₩17.91 Billion | ▼ -96.6% |
| 2018 | 35.41x | ₩14.90 Billion | ₩420.84 Million | — |